Annual Cash & Cash Equivalents
$50.50 M
+$7.87 M+18.45%
December 1, 2023
Summary
- As of February 8, 2025, IRD annual cash & cash equivalents is $50.50 million, with the most recent change of +$7.87 million (+18.45%) on December 1, 2023.
- During the last 3 years, IRD annual cash & cash equivalents has risen by +$34.10 million (+207.95%).
- IRD annual cash & cash equivalents is now at all-time high.
Performance
IRD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$36.63 M
-$4.78 M-11.54%
September 1, 2024
Summary
- As of February 8, 2025, IRD quarterly cash and cash equivalents is $36.63 million, with the most recent change of -$4.78 million (-11.54%) on September 1, 2024.
- Over the past year, IRD quarterly cash and cash equivalents has dropped by -$10.53 million (-22.33%).
- IRD quarterly cash and cash equivalents is now -27.46% below its all-time high of $50.50 million, reached on December 1, 2023.
Performance
IRD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IRD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.4% | -22.3% |
| 3 y3 years | +207.9% | +49.3% |
| 5 y5 years | +3185.7% | +49.3% |
IRD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +105.8% | -27.5% | +164.4% |
| 5 y | 5-year | at high | +3185.7% | -27.5% | +245.7% |
| alltime | all time | at high | +3185.7% | -27.5% | +245.7% |
Opus Genetics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.63 M(-11.5%) |
| Jun 2024 | - | $41.41 M(-12.2%) |
| Mar 2024 | - | $47.16 M(-6.6%) |
| Dec 2023 | $50.50 M(+18.5%) | $50.50 M(+19.2%) |
| Sep 2023 | - | $42.35 M(+5.9%) |
| Jun 2023 | - | $39.98 M(+2.5%) |
| Mar 2023 | - | $38.99 M(-8.6%) |
| Dec 2022 | $42.63 M | $42.63 M(+207.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $13.86 M(-18.6%) |
| Jun 2022 | - | $17.02 M(-11.5%) |
| Mar 2022 | - | $19.25 M(-21.6%) |
| Dec 2021 | $24.53 M(+49.6%) | $24.53 M(+10.3%) |
| Sep 2021 | - | $22.25 M(-8.2%) |
| Jun 2021 | - | $24.23 M(+128.7%) |
| Mar 2021 | - | $10.60 M(-35.4%) |
| Dec 2020 | $16.40 M(+966.9%) | $16.40 M |
| Dec 2019 | $1.54 M | - |
FAQ
- What is Opus Genetics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Opus Genetics?
- What is Opus Genetics annual cash & cash equivalents year-on-year change?
- What is Opus Genetics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Opus Genetics?
- What is Opus Genetics quarterly cash and cash equivalents year-on-year change?
What is Opus Genetics annual cash & cash equivalents?
The current annual cash & cash equivalents of IRD is $50.50 M
What is the all time high annual cash & cash equivalents for Opus Genetics?
Opus Genetics all-time high annual cash & cash equivalents is $50.50 M
What is Opus Genetics annual cash & cash equivalents year-on-year change?
Over the past year, IRD annual cash & cash equivalents has changed by +$7.87 M (+18.45%)
What is Opus Genetics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IRD is $36.63 M
What is the all time high quarterly cash and cash equivalents for Opus Genetics?
Opus Genetics all-time high quarterly cash and cash equivalents is $50.50 M
What is Opus Genetics quarterly cash and cash equivalents year-on-year change?
Over the past year, IRD quarterly cash and cash equivalents has changed by -$10.53 M (-22.33%)